( We provide with LRPAP1 qPCR primers for gene expression analysis, HP101015 )
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive ,Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag is a polypeptide protein tag derived from the c-myc gene product that can be added to a protein using recombinant DNA technology. It can be used for affinity chromatography, then used to separate recombinant, overexpressed protein from wild type protein expressed by the host organism. It can also be used in the isolation of protein complexes with multiple subunits.
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, C-GFPSpark tag||HG11100-ACG|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, C-OFPSpark tag||HG11100-ACR|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, C-Flag tag||HG11100-CF|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, C-His tag||HG11100-CH|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, C-Myc tag||HG11100-CM|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, C-HA tag||HG11100-CY|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone in cloning vector||HG11100-M|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, C-Flag tag||HG11100-M-F|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, N-Flag tag||HG11100-NF|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, N-His tag||HG11100-NH|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, N-Myc tag||HG11100-NM|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid, N-HA tag||HG11100-NY|
|Human LRPAP1/A2MRAP Gene ORF cDNA clone expression plasmid||HG11100-UT|
|Learn more about expression Vectors|
Receptor-associated protein (RAP) is a molecular chaperone for low density lipoprotein receptor-related protein (LRP), which plays a key role in cholesterol metabolism. The lipoprotein receptor-related protein (LRP) is an endocytic receptor for several ligands, such as alpha2-macroglobulin (alpha2 M) and apolipoprotein E. LRP is involved in the clearance of lipids from the bloodstream and is expressed in the atherosclerotic plaque. The LRP-associated protein (LRPAP in humans, RAP in mice) acts as a chaperone protein, stabilizing the nascent LRP peptide in the endoplasmic reticulum and Golgi complex. Alpha-2-macroglobulin receptor-associated protein, also known as low density lipoprotein receptor-related protein-associated protein 1, RAP and LRPAP1, is a 39 kDa protein and a member of the alpha-2-MRAP family. It is a receptor antagonist that interacts with several members of the low density lipoprotein (LDL) receptor gene family. Upon binding to these receptors, LRPAP1 inhibits all ligand interactions with the receptors. LRPAP1 is present on cell surface forming a complex with the alpha-2-macroglobulin receptor heavy and light chains. It binds with LRP1B and the binding is followed by internalization and degradation. LRPAP1 interacts with LRP1/alpha-2-macroglobulin receptor and LRP2 (previously called glycoprotein 330), and may be involved in the pathogenesis of membrane glomerular nephritis. LRPAP1 together with LRP2 forms the Heymann nephritis antigenic complex. LRP2 is expressed in epithelial cells of the thyroid, where it can serve as a receptor for the protein thyroglobulin. Intron 5 insertion/deletion polymorphism of RAP gene (LRPAP1) has been implicated in other diseases sharing etiology with gallstone disease (GSD). The LRPAP1 insertion/deletion polymorphism influences cholesterol homeostasis and may confer risk for gallstone disease and gallbladder carcinoma (GBC) incidence usually parallels with the prevalence of cholelithiosis. The genetic variations at the LRPAP1 locus may modulate Alzheimer disease (AD) phenotype beyond risk for disease. In addition, the variation at the LRPAP1 gene could contribute to the risk of developing an early episode of myocardial infarction (MI).